The Beneficial Effect of Low-Dose Aspirin on the Survival of Pathological Advanced-Stage Oral Squamous Cell Carcinoma Patients Research Square 2021, DOI: https://doi.org/10.21203/rs.3.rs-193987/v1(non-SCI)
Stigma, depression, and anxiety among patients with head and neck cancer Supportive Care in Cancer 2021, https://doi.org/10.1007/s00520-021-06550-w(non-SCI)
Quality of Life as a Mediator between Cancer Stage and Long-Term Mortality in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Radiotherapy Cancers 2021, 13, 5063. (SCI, IF=6.639 Oncology 51/242)
Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma J. Clin. Med. 2021, 10, 4118. https://doi.org/10.3390/ jcm10184118. (SCI, IF=4.242 Medicine, general & Internal 39/167)
Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma International Journal of Molecular Sciences 2021, 22, 3046. https://doi.org/10.3390/ijms22063046. (SCI, IF=5.924 Biochemistry & Molecular Biology 67/295)
Survival Outcomes and Predictors for Patients who Failed Chemoradiotherapy/Radiotherapy and Underwent Salvage Total Laryngectomy International Journal of Environmental Research and Public Health 2021, 18, 371. https://doi.org/10.3390/ijerph18020371. (SCI, IF=3.390 Public, environmental & Occupational health 68/203)
Low?dose aspirin confers a survival benefit in patients with pathological advanced?stage oral squamous cell carcinoma Scientific Reports 2021, 11:17161.https://doi.org/10.1038/s41598-021-96614-y. (SCI, IF=4.379 Multidisciplinary sciences 17/73)�
History of Surgical Intervention Is an Independent Prognostic Factor Among Patients With Synchronous Laryngeal/Pharyngeal and Supracarinal Esophageal Cancer. International Journal of Head and Neck Science 2020, 4(4): 174-185, DOI:10.6696/IJHNS.202012_4(4).0005(non-SCI)
Gross tumor volume determines toxicity and quality of life for patients with nasopharyngeal carcinoma treated by concurrent chemoradiotherapy with simultaneously integrated boost technique Research Square 2020, DOI: https://doi.org/10.21203/rs.3.rs-29555/v1(non-SCI)
Risk Prediction of Radiation-Induced Hepatic Toxicity Complications in Patients with Hepatocellular Carcinoma. Research Square 2020, DOI:https://doi.org/10.21203/rs.3.rs-110762/v1(non-SCI)
Treatment of p16-Negative Advanced Tonsil Cancer: Primary Surgery or Primary Radiation? International Journal of Head and Neck Science 2020, 4(1): 24-33(non-SCI)
Automatic mantispid egg detection and counting using image nature. International Journal of Modern Physics B (2020) 2040138(SCI, IF=1.219 Physics, mathematical 34/55)
Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy. Radiation Oncology (2020) 15:84. (SCI, IF=3.481 Radiology nuclear medicine & medical imaging 50/133)
Clinical significance of pretreatment prognostic nutritional index and lymphocyte-to-monocyte ratio in patients with advanced p16-negative oropharyngeal cancer—a retrospective study Peer J 2020, DOI 10.7717/peerj.10465. (SCI, IF=2.984 Multidisciplinary sciences 27/71)
Analyzing the association between dose-volume parameters and radiation-induced brain edema in patients with brain tumor receiving stereotactic radiosurgery. International Journal of Modern Physics B (2020) 2040134. (SCI, IF=1.219 Physics, mathematical 34/55)
The Clinical Impacts of Pretreatment Peripheral Blood Ratio on Lymphocytes, Monocytes, and Neutrophils Among Patients with Laryngeal/ Hypopharyngeal Cancer Treated by Chemoradiation/ Radiation. Cancer Management and Research 2020:12 9013–9021. (SCI, IF=3.989 Oncology 129/242)
Predictors of hospital expenses and hospital stay among patients undergoing total laryngectomy: Cost effectiveness analysis ID.PLOS ONE | https://doi.org/10.1371/journal.pone.0236122 July 16, 2020:1-11. (SCI, IF=3.240 Multidisciplinary sciences 26/71)
Low-Dose Aspirin Use Significantly Improves the Survival of Late-Stage NPC: A Propensity Score-Matched Cohort Study in Taiwan. Cancers 2020, 12, 1551; doi:10.3390/cancers12061551. (SCI, IF=6.639 Oncology 51/242)
Evaluating the risk factors of post inflammatory hyperpigmentation complications with Nd-YAG laser toning using LASSO-based algorithm. Appl. Sci. 2020, 10, 2049; doi:10.3390/app10062049. (SCI, IF=2.679 Engineering, Multidisciplinary 38/90)
Concurrent chemoradiotherapy by simultaneously integrated boost volumetric-modulated arc therapy for nasopharyngeal carcinoma-toxicity/quality of life and survival. Head & Neck. 2019; 41:1282–1289. (SCI, IF=3.147 Otorhinolaryngology 12/44)
Validation of the chinese version of the shame and stigma scale in patients with head and neck cancer Cancer Management Research 2019:11 10297-10305. (SCI, IF=3.989 Oncology 129/242)
Neutrophil lymphocyte ratio is an independent prognosticator in patients with locally advanced head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil. Journal of Cancer Research and Practice. 2019; 6:170-178. (non-SCI)
Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity- modulated radiotherapy Radiation Oncology 2018, 13:45. (SCI, IF=3.481 Radiology nuclear medicine & medical imaging 50/133)
Nox4 Overexpression as a Poor Prognostic Factor in Patients with Oral Tongue Squamous Cell Carcinoma Receiving Surgical Resection J. Clin. Med. 2018, 7, 497; doi:10.3390/jcm7120497. (SCI, IF=4.242 Medicine, general & Internal 39/167)
The Potential Role of Metformin in the Treatment of Head and Neck Squamous Cell Carcinoma. International Journal of Head and Neck Science 2018, 2(2): 50-55. (non-SCI)
Treatment Outcome of Patients with Unresectable Stage IVB Head and Neck Squamous Cell Carcinoma Receiving Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil International Journal of Head and Neck Science 2017, 1(2): 121-130(non-SCI)
Therapeutic outcome of nasopharyngeal carcinoma with cranial nerve palsy: a single institution experience of 104 patients OncoTargets and Therapy 2017:10 2069–2075. (SCI, IF=4.147 Biotechnology & Appied microbiology 53/159)
The Therapeutic Benefit of Radical Resection for T4b Oral Cavity Squamous Cell Carcinoma with Partial or Complete Response After Radical Chemo-Intensity-Modulated Radiotherapy (IMRT). Annals of surgical oncology. 2016; 23:866-873. (SCI, IF=5.344 Surgery 19/211)
Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil. Head and neck-journal for the sciences and specialties of the head and neck.2016;38:e844-e852. (SCI, IF=3.147 Otorhinolaryngology 12/44)
Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil. World journal of surgical oncology. 2016; 14:86. (SCI, IF=2.754 Surgery 86/211)
Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherap. Head and neck-journal for the sciences and specialties of the head and neck. 2016 ; 38 : e1026-1032. (SCI, IF=3.147 Otorhinolaryngology 12/44 First author)
Fang FM*, Chien CY, Tsai WL, Chen HC, Hsu HC, Lui CC, Huang TL, Huang HY. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy—A longitudinal study. International Journal of Radiation Oncology Biology Physics. 2008 Oct, 72 (2):356-364. (SCI；IF=4.592；RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING, 6/104）
Liu CT, Chiu TJ, Huang TL, Chien CY, Fang FM*. Impact of comorbidity on survival for locally advanced head and neck cancer patients treated by radiotherapy or radiotherapy plus chemotherapy. Chang Gung Medical Journal. 2010 May-Jun, 33(3):283-291
Fang FM*, Tsai WL, Chien CY, Chen HC, Hsu HC, Huang TL, Lee TF, Huang HY, Lee CH. Pretreatment quality of life as a predictor of distant metastasis and survival for patients with nasopharyngeal carcinoma. Journal of Clinical Oncology. 2010 Oct, 28(28):4384-4389. (SCI；IF=17.793；ONCOLOGY, 4/165).
Tai-Lin Huang, Chien-Feng Li, Hsuan-Ying Huang, Fu-Min Fang*. Expression of epidermal growth factor receptor(EGFR),phosphorylated EGFR and cyclooxygenase-2 in nasopharyngeal carcinomas: immunohistochemical analysis of 170 cases shows no significant correlations with clinicopathological variables and treatment outcomes. Chang Gung Medical Journal. 2010
Huang TL, Tsai WL, Chien CY, Lee TF, Fang FM*. Quality of life for head and neck cancer patients treated by combined modality therapy: the therapeutic benefit of technological advances in radiotherapy. Quality of Life Research. 2010 Jun 11 [Epub ahead of print] (SCI；IF=2.376；HEALTH CARE SCIENCES & SERVICES, 20/69)
